Position in TECH
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$1,172,790
+$367,568 QoQ
Shares Held
16,600
+7.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#272
of 588 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rakuten Investment Management, Inc. holds $59,330,921 across 7 Biotechnology names. TECH ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
61,183 | $30,391,431 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24,580 | $15,326,613 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,961 | $5,406,799 | |
| 4 | INCY |
Incyte Corp
|
27,525 | $3,120,234 | |
| 5 | MRNA |
Moderna, Inc.
|
37,441 | $2,621,993 | |
| 6 | INSM |
INSMED Inc
|
12,109 | $1,291,061 | |
| 7 | TECH |
BIO-TECHNE Corp
This page
|
16,600 | $1,172,790 |
All Filings in TECH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,172,790 | 16,600 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $805,222 | 15,408 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $817,282 | 13,897 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,960 | 215 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $848,434 | 14,471 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $713,694 | 8,929 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $480,341 | 6,704 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $298,172 | 4,236 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $30,169 | 391 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||